Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05966675 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Physiologic Cardiac Pacing to Prevent Left Ventricular Dysfunction Post TAVI

Study acronym: PACE-4-TAVI
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Oct 1, 2023 to Feb 27, 2024
    • Site details revised
    v3
  2. Start date: Jul 2023 to Oct 1, 2023
    • Secondary endpoints: details revised at 1 of 8 entries
    • Site contact updated
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study aims to compare permanent Conduction System Pacing (CSP) with the standard therapy - Right Ventricular Pacing (RVP) or Biventricular Pacing (BVP) - in preventing the development and progression of symptomatic Chronic Heart Failure (CHF) and improving survival in patients after Transcatheter Aortic Valve Implantation (TAVI).
Trial Details
NCT Number NCT05966675
Lead Sponsor Medical University of Silesia
Collaborators: Medical Research Agency, Poland
Conditions
(from sponsor)		 Atrioventricular Block, Second and Third Degree
Related terms Atrioventricular Block, Bradycardia, Heart Failure, Neoplasm Metastasis
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov